Mirna Therapeutics is harnessing the power of tumor suppressor micro RNAs (miRNAs) to kill cancer cells by regaining control over multiple oncogenic pathways. Tumor suppressor miRNAs represent a new paradigm in cancer therapy. Mirna's miRNA 'mimic pipeline' has broad therapeutic utility in solid and hematologic cancers as well as other therapeutic areas, and provides multiple opportunities for partnering and licensing.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/24/12 | $34,500,000 | Series C |
Correlation Ventures Osage University Partners Pfizer Venture Investments Sofinnova Ventures | undisclosed |
